Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease.

Overview of attention for article published in NEJM Evidence, August 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog
twitter: 13 X users

bluesky: 3 Bluesky users

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 13 X posts from 13 X users, with an upper bound of 28,238 followers.

RT @arvindcanchi: @NephroSeeker @ECNeph @ISNeducation @isn_india @drshyambansal @SreejithDr @thisis_drgsp @myadla @priti899 @AnandhUrmila @…

@NephroSeeker @ECNeph @ISNeducation @isn_india @drshyambansal @SreejithDr @thisis_drgsp @myadla @priti899 @AnandhUrmila @hswapnil Agree Re short follow-up, need more time esp in tx pts to look at adverse events such as cancer/effects on the graft kidney…

RT @dgfn_ev: Once developped to partly replace ESA and EPO with their cardiovascular side-effects, HIF stabilizers turn out to be not bette…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 9 additional X posts.